Skip to main content
. 2016 Oct 14;95(41):e5146. doi: 10.1097/MD.0000000000005146

Figure 2.

Figure 2

The rates of virologic failure with resistance and subgroup analysis compared TAF vs TDF at week 48. (A) Virologic failure with resistance. (B) Subgroup analysis of virologic failure with resistance comparing naive and switch patients. TAF = tenofovir alafenamide, TDF = tenofovir disoproxil fumarate.